Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients

被引:24
作者
Taniguchi, A [1 ]
Fukushima, M
Ohya, M
Nakai, Y
Yoshii, S
Nagasaka, S
Matsumoto, K
Taki, Y
Kuroe, A
Nishimura, F
Seino, Y
机构
[1] Kansai Denryoku Hosp, Div Diabet & Clin Nutr, Osaka 5530003, Japan
[2] Fdn Biochem Res & Innovat, Translat Res Informat Ctr, Dept Hlth Informat Res, Kobe, Hyogo 6500047, Japan
[3] Kyoto Univ, Grad Sch Med, Sch Hlth Sci, Fac Med, Kyoto 6068507, Japan
[4] Jichi Med Sch, Div Endocrinol & Metab, Minami Kawachi, Tochigi 7000045, Japan
[5] Sasebo Chuo Hosp, Ctr Diabet, Nagasaki 8570044, Japan
[6] Okayama Univ, Grad Sch Med & Dent, Dept Pathophysiol Peridontal Sci, Okayama, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2006年 / 55卷 / 02期
关键词
D O I
10.1016/j.metabol.2005.08.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to investigate the relationships between interleukin 6 (IL-6) and insulin resistance, serum leptin, serum adiponectin, or serum lipids including triglycerides in 98 nonobese Japanese type 2 diabetic patients. Insulin resistance was estimated by the insulin resistance index of homeostasis model assessment (HOMA-IR). Serum IL- 6 concentration was negatively correlated to high-density lipoprotein cholesterol (r = -0.295, P =.004), but was not associated with HOMA-IR (r = 0.016, P =.871), body mass index (BMI) (r = 0.090, P =.375), systolic (r = 0.169, P =.116) and diastolic (r = -0.061, P =.570) blood pressures, leptin (r = 0.062, P.544), and adiponectin (r = -0.020, P =.841) in these patients. In contrast, serum leptin level was positively correlated to HOMA-IR (r = 0.291, P =.004), BMI (r = 0.338, P <.001), and systolic blood pressure (r = 0.241, P =.025). Serum adiponectin level was negatively correlated to HOMA-IR (r = -0.288, P =.005), BMI (r = -0.308, P =.002), diastolic blood pressure (r = -0.269, P =.012), and triglycerides (r = - 0.338, P <.001), and positively correlated to high-density lipoprotein cholesterol (r = 0.300, P =.003) in our patients. From these results, it can be suggested that fasting serum IL-6 is not a major factor responsible for the evolution of insulin resistance in nonobese Japanese type 2 diabetic patients. (c) 2006 Published by Elsevier Inc.
引用
收藏
页码:258 / 262
页数:5
相关论文
共 32 条
[1]   Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM [J].
Abate, N ;
Garg, A ;
Peshock, RM ;
StrayGundersen, J ;
AdamsHuet, B ;
Grundy, SM .
DIABETES, 1996, 45 (12) :1684-1693
[2]   DOES INTRAABDOMINAL ADIPOSE-TISSUE IN BLACK-MEN DETERMINE WHETHER NIDDM IS INSULIN-RESISTANT OR INSULIN-SENSITIVE [J].
BANERJI, MA ;
CHAIKEN, RL ;
GORDON, D ;
KRAL, JG ;
LEBOVITZ, HE .
DIABETES, 1995, 44 (02) :141-146
[3]   Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].
Bastard, JP ;
Jardel, C ;
Bruckert, E ;
Blondy, P ;
Capeau, J ;
Laville, M ;
Vidal, H ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342
[4]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[5]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[6]   Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes:: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness [J].
Carey, AL ;
Bruce, CR ;
Sacchetti, M ;
Anderson, MJ ;
Olsen, DB ;
Saltin, B ;
Hawley, JA ;
Febbraio, MA .
DIABETOLOGIA, 2004, 47 (06) :1029-1037
[7]  
CARLEY AL, 2004, DIABETOLOGIA, V47, P1135
[8]   PATTERNS OF GLUCOSE AND LIPID ABNORMALITIES IN BLACK NIDDM SUBJECTS [J].
CHAIKEN, RL ;
BANERJI, MA ;
PASMANTIER, R ;
HUEY, H ;
HIRSCH, S ;
LEBOVITZ, HE .
DIABETES CARE, 1991, 14 (11) :1036-1042
[9]   Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas [J].
Emoto, M ;
Nishizawa, Y ;
Maekawa, K ;
Hiura, Y ;
Kanda, H ;
Kawagishi, T ;
Shoji, T ;
Okuno, Y ;
Morii, H .
DIABETES CARE, 1999, 22 (05) :818-822
[10]   Interleukin-6 gene polymorphism and insulin sensitivity [J].
Fernández-Real, JM ;
Broch, M ;
Vendrell, J ;
Gutiérrez, C ;
Casamitjana, R ;
Pugeat, M ;
Richart, C ;
Ricart, W .
DIABETES, 2000, 49 (03) :517-520